Seppo W. Langer

Seppo W. Langer

Clinical Associate Professor

Member of:

  • Clinical Oncology

ORCID: 0000-0001-9732-9192

Publication year:
All
151 - 160 out of 174Page size: 10
  1. 2003
  2. Published

    Plantar-palmar erytrodysaestesi. En ny og relativt hyppigt forekommende bivirkning ved antineoplastisk behandling

    Risum, S. & Langer, Seppo W., 11 Aug 2003, In: Ugeskrift for Laeger. 165, 33, p. 3161-2 2 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Plantar-palmar erytrodysæstesi. En ny og relativt hyppigt forekommende bivirkning ved antineoplastisk behandling

    Risum, S. & Langer, Seppo W., 11 Aug 2003, In: Ugeskrift for Laeger. 165, 33, p. 3161-3162 2 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Metabolism of dexrazoxane (ICRF-187) used as a rescue agent in cancer patients treated with high-dose etoposide

    Schroeder, P. E., Jensen, P. B., Sehested, M., Hofland, K. F., Langer, Seppo W. & Hasinoff, B. B., Aug 2003, In: Cancer Chemotherapy and Pharmacology. 52, 2, p. 167-74 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Dexrazoxane-a promising antidote in the treatment of accidental extravasation of anthracyclines

    Jensen, J. N., Lock-Andersen, J., Langer, Seppo W. & Mejer, J., 2003, In: Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery. 37, 3, p. 174-5 2 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. 2002
  7. Published

    Maleimide is a potent inhibitor of topoisomerase II in vitro and in vivo: a new mode of catalytic inhibition

    Jensen, L. H., Renodon-Corniere, A., Wessel, I., Langer, Seppo W., Søkilde, B., Carstensen, E. V., Sehested, M. & Jensen, P. B., May 2002, In: Molecular Pharmacology. 61, 5, p. 1235-43 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. 2001
  9. Published

    Dexrazoxane is a potent and specific inhibitor of anthracycline induced subcutaneous lesions in mice

    Langer, Seppo W., Sehested, M. & Jensen, P. B., Mar 2001, In: Annals of oncology : official journal of the European Society for Medical Oncology. 12, 3, p. 405-10 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. 2000
  11. Published

    Dexrazoxane in anthracycline extravasation

    Langer, Seppo W., Sehested, M., Jensen, P. B., Buter, J. & Giaccone, G., Aug 2000, In: Journal of Clinical Oncology. 18, 16, p. 3064

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Published

    Dexrazoxane in anthracycline extravasation [4]

    Langer, Seppo W., Sehested, M., Jensen, P. B., Buter, J. & Giaconne, G., 2000, In: Journal of Clinical Oncology. 18, 16, p. 3064 1 p.

    Research output: Contribution to journal › Letter › Research › peer-review

  13. Published

    Treatment of anthracycline extravasation with dexrazoxane

    Langer, Seppo W., Sehested, M. & Jensen, P. B., 2000, In: Clinical Cancer Research. 6, 9, p. 3680-3686 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  14. 1999
  15. Published

    Twenty-five years of chemotherapy in small cell lung cancer sends us back to the laboratory

    Jensen, P. B., Sehested, M., Langer, Seppo W. & Hansen, H. H., Dec 1999, In: Cancer Treatment Reviews. 25, 6, p. 377-386 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1...12 13 14 15 16 17 18 Next

ID: 33841728